What’s Analyzed
[ 108+ Genes · 6 Syndrome Groups ]GeneCancer doesn’t screen for one type — it analyzes 108+ genes across all major hereditary cancer syndromes so nothing is missed.
Breast & Ovarian Cancer
Lynch Syndrome & Colorectal
Prostate Cancer
Melanoma & Skin Cancer
Li-Fraumeni & Rare Syndromes
Pancreatic & Gastric Cancer
Your family history has answers in your genes
[ Key Genes + Answers ]“My mother had breast cancer. Am I at risk?”
[ What the science says ]BRCA1 and BRCA2 mutations are inherited — if your mother had breast or ovarian cancer caused by a BRCA mutation, you have a 50% chance of carrying the same mutation. Women with BRCA1 mutations have up to a 72% lifetime breast cancer risk compared to 12% in the general population.
GeneCancer analyzes BRCA1, BRCA2, PALB2, ATM, CHEK2, and 9 more breast cancer genes — giving you and your doctor a complete hereditary risk picture to build a proactive surveillance plan.
“Multiple family members have had colon cancer. Should I be worried?”
[ What the science says ]Lynch Syndrome is the most common hereditary colorectal cancer syndrome, caused by mutations in DNA mismatch repair genes. People with Lynch Syndrome have up to an 80% lifetime colon cancer risk — but with proper surveillance (colonoscopy every 1-2 years starting at 20-25), most Lynch Syndrome-related cancers are found early and treated successfully.
GeneCancer tests all five Lynch Syndrome genes (MLH1, MSH2, MSH6, PMS2, EPCAM) and provides a personalized colonoscopy schedule if a mutation is found.
“I’m a man. Do I really need hereditary cancer testing?”
[ What the science says ]Men with BRCA2 mutations have a 7% lifetime risk of breast cancer (vs. 0.1% normally) and up to 27% risk of prostate cancer by age 80. The HOXB13 gene dramatically raises aggressive prostate cancer risk. Lynch Syndrome in men raises colorectal, stomach, and urothelial cancer risk. These aren’t just women’s issues.
GeneCancer’s male-specific reporting highlights prostate cancer risk genes, Lynch Syndrome variants, and BRCA2 — with PSA screening recommendations tailored to your specific genetic profile.
How It Works
[ From Swab To Answers ]Your kit ships to your door
A lab-grade DNA collection kit arrives within 2-3 business days. Inside: a sterile saliva collection tube, clear instructions, and a prepaid return envelope. No lab visit. No needle. No hassle.
A 2-minute saliva sample at home
Just spit into the collection tube — that’s it. No needles, no clinic visits, no appointments. Cap it, seal the prepaid envelope, and drop it in any mailbox.
Our lab analyzes 108+ cancer genes
Your sample is processed in our CLIA-certified, CAP-accredited laboratory using our proprietary MassArray Sequencing technology — ultra-precise variant detection across all 108+ cancer-related genes. Board-certified geneticists review every finding.
Your personalized report — yours for life
In 5–7 days, receive a comprehensive, easy-to-read cancer risk report covering all 15+ cancer types. Share it with any oncologist, gynecologist, or primary care physician. Your results never expire — your DNA doesn’t change.
What’s in your report
- Board-certified report with gene findings & risk scores
- NCCN-aligned screening plan covering 15+ cancer types
- Personalized colonoscopy schedule if a mutation is found
- Male-specific reporting — prostate, Lynch & BRCA2
- Insurance documentation to support reimbursement
- Shareable with any oncologist or physician — forever
Included With Your Membership
[ GeneCancer + 10 More Tests ]GeneCancer is included with your Gene Matrix Membership — along with all 10 other genetic tests. No per-test fees. No surprises.
A standalone panel at typical lab pricing — a separate order, a separate kit, and a report that never updates.
This test individually: $499. With your membership: included at $89/mo (or $59/mo billed annually) along with all 10 other tests.
No per-test fees. No surprises. 30-day guarantee. HSA/FSA eligible.
The gene that changed everything
[ Verified Results ]“My mother had breast cancer at 42. I finally got tested and found out I carry a BRCA2 variant. My doctor immediately put me on an enhanced screening protocol. That test may have saved my life.”
Jennifer K. — Chicago, IL · BRCA2 pathogenic variant detected
Frequently asked
GeneCancer is recommended for individuals with a family history of cancer, multiple cancer diagnoses in the family, cancer at young ages, or specific cancer types like breast, ovarian, or colorectal cancer. It’s also valuable for anyone wanting proactive insight into their hereditary cancer risk.
We analyze 108+ genes including BRCA1, BRCA2, PALB2, ATM, CHEK2, Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2), TP53, PTEN, APC, CDKN2A, STK11, and many others associated with hereditary cancer syndromes covering 15+ cancer types.
Our test has 99.9% analytical accuracy and is performed in CLIA-certified, CE-IVD Certified laboratories using Illumina next-generation sequencing technology. All results are reviewed by board-certified geneticists before release.
Many insurance plans cover genetic testing for individuals who meet specific criteria (family history, personal cancer history). We provide detailed documentation to help with insurance reimbursement and our team can help verify your coverage.
A positive result means you have an increased risk for certain cancers. You’ll receive personalized screening recommendations, prevention strategies, and can consult with a genetic counselor. Many hereditary cancers are highly preventable with proper surveillance.
We use 256-bit encryption for all data transmission and storage. Your genetic information is never shared with third parties without explicit consent. We are fully HIPAA and GDPR compliant, and you can request data deletion at any time.